GB201516781D0
|
|
Process
|
GB201515833D0
|
|
Implantable sensor system with near field communication
|
GB201512233D0
|
|
Dynamic logic circuit
|
WO2015169853A1
|
|
Engineered invariant chain molecule for improved mhc class i loading
|
GB201417076D0
|
|
Process
|
GB201405837D0
|
|
Segmentation of tubular organ structures
|
WO2014111476A1
|
|
Langmuir probe
|
GB201320506D0
|
|
Cyclic amino compounds for the use in the treatment of cardiac disorders
|
GB201319363D0
|
|
Compounds
|
US2014119627A1
|
|
Method for improved estimation of tracer uptake in physiological image volumes
|
GB201317970D0
|
|
Method
|
GB201317619D0
|
|
Compounds
|
GB201312311D0
|
|
Uses of enzyme inhibitors
|
GB201305679D0
|
|
Carbonic anhydrase inhibitors
|
GB201217084D0
|
|
Network security
|
WO2013011297A1
|
|
Method
|
GB201208775D0
|
|
Chemical compounds
|
WO2012136813A2
|
|
Agents for medical radar diagnosis
|
GB201204596D0
|
|
Method
|
WO2012117107A1
|
|
Method of determining wether a subject is resistant to chemotherapy with dna damaging agents
|